Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease

BACKGROUND: Patients with severe‐stage chronic kidney disease (CKD) were excluded from femoropopliteal disease trials evaluating drug‐coated balloons (DCBs) and drug‐eluting stents (DESs) versus plain balloon angioplasty (POBA) and bare metal stents (BMSs). We examined the interaction between CKD st...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Jonathan, Smolderen, Kim G., Castro‐Dominguez, Yulanka, Romain, Gaëlle, Lee, Megan, Turner, Jeffrey, Mena‐Hurtado, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122876/
https://www.ncbi.nlm.nih.gov/pubmed/36974774
http://dx.doi.org/10.1161/JAHA.122.028622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122876/
https://www.ncbi.nlm.nih.gov/pubmed/36974774
http://dx.doi.org/10.1161/JAHA.122.028622

Ejemplares similares